Updates in BCMA-directed therapies in multiple myeloma from ASH 2024
touchCONGRESS for touchHAEMATOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
Prof. Roman Hájek, University Hospital…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.